Table 1. Demographic and clinical features of the control, POAG, PACG and PEXG cohorts.
Controls | POAG | p-value | PACG | p-value | PEXG | p-value | |
Age | 48.1±13.2 | 48.3±16.5 | >0.05 | 45.5.±16.5 | >0.05 | 50.09±14.1 | >0.05 |
Gender | |||||||
Males | 52% | 51% | >0.05 | 49.5% | >0.05 | 48% | >0.05 |
Females | 48% | 49% | 50.5% | 52% | |||
IOP | 16.4±2.3 | 30.5±11.6 | <0.05 | 26.4±10.2 | <0.05 | 28.4±10.5 | <0.05 |
CDR | 0.39±0.18 | 0.85±.63 | <0.05 | 0.67±.27 | <0.05 | 0.76±.23 | <0.05 |